<?xml version="1.0" encoding="utf-8" standalone="no"?>
<dublin_core schema="dc">
<dcvalue element="contributor" qualifier="author">Kim,&#x20;So-Young</dcvalue>
<dcvalue element="contributor" qualifier="author">Park,&#x20;Hyeong&#x20;Beom</dcvalue>
<dcvalue element="contributor" qualifier="author">Cho,&#x20;Jung-Hyuck</dcvalue>
<dcvalue element="contributor" qualifier="author">Yoo,&#x20;Kyung&#x20;Ho</dcvalue>
<dcvalue element="contributor" qualifier="author">Oh,&#x20;Chang-Hyun</dcvalue>
<dcvalue element="date" qualifier="accessioned">2024-01-20T21:31:29Z</dcvalue>
<dcvalue element="date" qualifier="available">2024-01-20T21:31:29Z</dcvalue>
<dcvalue element="date" qualifier="created">2021-09-03</dcvalue>
<dcvalue element="date" qualifier="issued">2009-05-01</dcvalue>
<dcvalue element="identifier" qualifier="issn">0960-894X</dcvalue>
<dcvalue element="identifier" qualifier="uri">https:&#x2F;&#x2F;pubs.kist.re.kr&#x2F;handle&#x2F;201004&#x2F;132496</dcvalue>
<dcvalue element="description" qualifier="abstract">The&#x20;synthesis&#x20;of&#x20;a&#x20;new&#x20;series&#x20;of&#x20;oxazolidinones&#x20;having&#x20;spiro[2,4]heptane&#x20;moieties&#x20;is&#x20;described.&#x20;Their&#x20;in&#x20;vitro&#x20;antibacterial&#x20;activities&#x20;against&#x20;both&#x20;Gram-positive&#x20;and&#x20;Gram-negative&#x20;bacteria&#x20;were&#x20;tested&#x20;and&#x20;the&#x20;effect&#x20;of&#x20;substituents&#x20;on&#x20;the&#x20;oxazolidinone&#x20;ring&#x20;was&#x20;investigated.&#x20;A&#x20;particular&#x20;compound&#x20;Ih&#x20;having&#x20;fluoro&#x20;group&#x20;showed&#x20;the&#x20;most&#x20;potent&#x20;antibacterial&#x20;activity.&#x20;(C)&#x20;2009&#x20;Published&#x20;by&#x20;Elsevier&#x20;Ltd.</dcvalue>
<dcvalue element="language" qualifier="none">English</dcvalue>
<dcvalue element="publisher" qualifier="none">Pergamon&#x20;Press&#x20;Ltd.</dcvalue>
<dcvalue element="subject" qualifier="none">CONFORMATIONALLY&#x20;CONSTRAINED&#x20;ANALOGS</dcvalue>
<dcvalue element="subject" qualifier="none">IN-VITRO&#x20;ACTIVITY</dcvalue>
<dcvalue element="subject" qualifier="none">TRICYCLIC&#x20;OXAZOLIDINONES</dcvalue>
<dcvalue element="subject" qualifier="none">RESISTANCE</dcvalue>
<dcvalue element="subject" qualifier="none">QUINOLONE</dcvalue>
<dcvalue element="subject" qualifier="none">SAR</dcvalue>
<dcvalue element="title" qualifier="none">Synthesis&#x20;and&#x20;antibacterial&#x20;activities&#x20;of&#x20;novel&#x20;oxazolidinones&#x20;having&#x20;spiro[2,4]heptane&#x20;moieties</dcvalue>
<dcvalue element="type" qualifier="none">Article</dcvalue>
<dcvalue element="identifier" qualifier="doi">10.1016&#x2F;j.bmcl.2009.03.025</dcvalue>
<dcvalue element="description" qualifier="journalClass">1</dcvalue>
<dcvalue element="identifier" qualifier="bibliographicCitation">Bioorganic&#x20;&amp;&#x20;Medicinal&#x20;Chemistry&#x20;Letters,&#x20;v.19,&#x20;no.9,&#x20;pp.2558&#x20;-&#x20;2561</dcvalue>
<dcvalue element="citation" qualifier="title">Bioorganic&#x20;&amp;&#x20;Medicinal&#x20;Chemistry&#x20;Letters</dcvalue>
<dcvalue element="citation" qualifier="volume">19</dcvalue>
<dcvalue element="citation" qualifier="number">9</dcvalue>
<dcvalue element="citation" qualifier="startPage">2558</dcvalue>
<dcvalue element="citation" qualifier="endPage">2561</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scie</dcvalue>
<dcvalue element="description" qualifier="journalRegisteredClass">scopus</dcvalue>
<dcvalue element="identifier" qualifier="wosid">000265137100040</dcvalue>
<dcvalue element="identifier" qualifier="scopusid">2-s2.0-64249111052</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Chemistry,&#x20;Medicinal</dcvalue>
<dcvalue element="relation" qualifier="journalWebOfScienceCategory">Chemistry,&#x20;Organic</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Pharmacology&#x20;&amp;&#x20;Pharmacy</dcvalue>
<dcvalue element="relation" qualifier="journalResearchArea">Chemistry</dcvalue>
<dcvalue element="type" qualifier="docType">Article</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">CONFORMATIONALLY&#x20;CONSTRAINED&#x20;ANALOGS</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">IN-VITRO&#x20;ACTIVITY</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">TRICYCLIC&#x20;OXAZOLIDINONES</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">RESISTANCE</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">QUINOLONE</dcvalue>
<dcvalue element="subject" qualifier="keywordPlus">SAR</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">Oxazolidinones</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">Antibacterial&#x20;activity</dcvalue>
<dcvalue element="subject" qualifier="keywordAuthor">Spiro[2,4]heptane</dcvalue>
</dublin_core>
